No evidence for the involvement of histamine (H1 or H2) receptors in the hypotension and presynaptic inhibition of sympathetic nerve function caused by LY-141865 in dogs.
LY-141865, a partial ergoline, caused hypotension, bradycardia and significant impairment of cardioacceleration elicited during stimulation of cardiac sympathetic nerves. These cardiovascular actions of LY-141865 were not affected either by the H1-receptor antagonist mepyramine or the H2-receptor antagonist cimetidine. The dopamine receptor antagonist sulpiride significantly reduced the hypotensive, bradycardic and presynaptic inhibitory actions of LY-141865. These results show that while dopamine receptor activation is responsible for the hypotension and presynaptic inhibition of sympathetic nerve function caused by LY-141865, histamine (H1- or H2-) receptors do not play any role in these actions of the compound.